Further Development of Artificial Pancreas: Blocked by Patents?
نویسندگان
چکیده
منابع مشابه
Further development of artificial pancreas: blocked by patents?
Patent activity in the field of medical device technology and especially in the area of artificial pancreas development has surged in recent years. According to the search presented in this article, the number of granted U.S. patents in the area of closed-loop glucose control (CLGC) increased from 24 filed in 1991 to 247 filed in 2001. A company active in the area of diabetes technology develop...
متن کاملDevelopment of Artificial Pancreas
Diabetic patients who have an abnormal blood glucose level suffer from acute effects of hypoglycemia and long term effects of hyperglycemia which include disorders of eyes, kidneys and nerves. This paper introduces the concept of an artificial pancreas which is a revolutionary device for the diabetic population. The artificial pancreas (AP), known as closed-loop control of blood glucose in diab...
متن کاملProgress in development of an artificial pancreas.
This issue of Journal of Diabetes Science and Technology contains a collection of 12 original articles describing the latest advances in the development of algorithms for controlling insulin delivery in an artificial pancreas. Algorithms presented in this issue are affected by numerous quantifiable factors, including insulin pharmaco-kinetics, timing of meal carbohydrate appearance, meal size, ...
متن کاملArtificial three-dimensional niches deconstruct pancreas development in vitro.
In the context of a cellular therapy for diabetes, methods for pancreatic progenitor expansion and subsequent differentiation into insulin-producing beta cells would be extremely valuable. Here we establish three-dimensional culture conditions in Matrigel that enable the efficient expansion of dissociated mouse embryonic pancreatic progenitors. By manipulating the medium composition we generate...
متن کاملTelemedical Artificial Pancreas
DEBATE — The integration of continuous subcutaneous insulin infusion (CSII) (insulin pump therapy) and continuous interstitial glucose monitoring (CGM) appears to be an excellent solution for obtaining the desirable metabolic control for most insulin-treated subjects (1– 4). Several studies have suggested that CGM with readings in real-time (CGMRT) further improves blood glucose control (5–9). ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Diabetes Science and Technology
سال: 2008
ISSN: 1932-2968,1932-2968
DOI: 10.1177/193229680800200607